TRiCares Topaz for Severe Tricuspid Valve Regurgitation
The TRICURE EFS Study
Recruiting
N/A
Interventional Study
Tricuspid Valve Regurgitation
Heart Valve Diseases
Cardiovascular Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 15 (estimated)
- Sponsor
- TRiCares · Industry
Who this trial is looking for
This trial is looking for adults with severe tricuspid regurgitation who are considered at higher risk for surgery. Participants will be evaluated by a heart team and may receive a new heart valve device.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult patient.
- I have severe tricuspid regurgitation.
- I have been evaluated by a heart team and considered at increased risk for surgery.
You may not be able to join if
- I need emergency surgery.
- I am hemodynamically unstable.
- I have anatomical issues that prevent implantation of the study device.
- I am currently in another clinical trial that has not finished.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients
* Tricuspid regurgitation grade 3 (severe) on a scale of 0 (none) to 5 (torrential)
* Institutional Heart Team evaluates patient as being at increased operative risk
Exclusion Criteria:
* Patient in need of emergent intervention
* Patient who is hemodynamicall…
Contacts